Table of Contents
Introduction: Three Pathways to Metabolic Enhancement
MOTS-c, SLU-PP-332, and AOD 9604 all improve metabolic parameters and promote fat loss in research models, but through three entirely different mechanisms. MOTS-c activates AMPK (the cellular energy sensor). SLU-PP-332 activates ERR? (an exercise-responsive nuclear receptor). AOD 9604 stimulates ?3-adrenergic receptor-mediated lipolysis (the GH fat-burning pathway). Understanding these distinctions is critical for protocol design.
MOTS-c: The Mitochondrial Metabolic Peptide
MOTS-c is a 16-amino-acid mitochondrial-derived peptide that activates AMPK, improving glucose uptake, insulin sensitivity, and fatty acid oxidation. Discovered at USC in 2015, it functions as an exercise mimetic by engaging the same metabolic pathways activated during physical exercise (PMID: 25738459). Circulating levels decline with age.
SLU-PP-332: The Exercise Mimetic
SLU-PP-332 is a small molecule agonist of estrogen-related receptor alpha (ERR?), a nuclear receptor that controls mitochondrial biogenesis and oxidative metabolism in muscle. It increases slow-twitch muscle fiber proportion, enhances endurance capacity, and promotes fat utilization — essentially mimicking the molecular adaptations of endurance exercise training without physical activity.
- ERR? activation: Drives mitochondrial biogenesis in skeletal muscle
- Fiber-type switching: Promotes slow-twitch (oxidative) over fast-twitch (glycolytic) fibers
- Endurance enhancement: Increased running endurance in mouse models
- Fat oxidation: Enhanced fatty acid utilization for energy
AOD 9604: The GH Fragment Lipolytic
AOD 9604 is the C-terminal fragment (amino acids 176-191) of human growth hormone with a tyrosine modification. It retains GH’s lipolytic activity through ?3-adrenergic receptor activation while eliminating growth-promoting, IGF-1-elevating, and diabetogenic effects (PMID: 11713213). GRAS status from Australia’s TGA.
Three-Way Comparison
| Feature | MOTS-c | SLU-PP-332 | AOD 9604 |
|---|---|---|---|
| Class | Mitochondrial peptide | Small molecule (ERR? agonist) | GH fragment peptide |
| Target | AMPK activation | ERR? nuclear receptor | ?3-adrenergic receptor |
| Fat Loss Mechanism | Fatty acid oxidation + glucose metabolism | Muscle fiber switching + fat utilization | Direct lipolysis + anti-lipogenesis |
| Muscle Effects | Metabolic improvement | Endurance enhancement, fiber-type change | None |
| Glucose/Insulin | Improves both | Indirect improvement | No effect |
| IGF-1 Effect | None | None | None |
| Exercise Mimetic | Yes (AMPK pathway) | Yes (ERR? pathway) | No (direct lipolysis only) |
Choosing the Right Peptide
Choose MOTS-c when:
- Metabolic syndrome, insulin resistance, or glucose homeostasis are endpoints
- AMPK biology and mitochondrial function are research questions
- Aging-related metabolic decline is the model
- A naturally-derived (mitochondrial genome) compound is preferred
Choose SLU-PP-332 when:
- Exercise physiology and endurance research are the focus
- Muscle fiber-type composition is an endpoint
- ERR?-mediated mitochondrial biogenesis is the research question
- Exercise mimetic effects in sedentary or immobilized models are desired
Choose AOD 9604 when:
- Pure fat reduction without muscle or hormonal effects is needed
- A compound with clinical trial data and GRAS status is required
- IGF-1 and glucose effects must be avoided
- GH-fragment-specific lipolysis is the research question
For appetite-mediated weight loss, compare with Semaglutide, Tirzepatide, or Retatrutide (GLP-1 receptor agonists).
Frequently Asked Questions
Which is the best fat loss peptide?
It depends on the mechanism you want to study. For metabolic improvement and insulin sensitivity, MOTS-c is strongest. For exercise-mimetic endurance and muscle adaptation, SLU-PP-332 is unique. For pure fat-targeted lipolysis without other effects, AOD 9604 is the cleanest. For appetite suppression, GLP-1 agonists like Semaglutide are most effective.
Can MOTS-c, SLU-PP-332, and AOD 9604 be combined?
They target three non-overlapping pathways (AMPK, ERR?, ?3-AR), so there is no receptor competition. A triple combination would engage metabolic sensing (MOTS-c), mitochondrial biogenesis (SLU-PP-332), and direct lipolysis (AOD 9604) simultaneously. However, no studies have evaluated this combination, and multi-compound protocols require careful dose management.
Do these peptides affect muscle mass?
SLU-PP-332 changes muscle composition (more slow-twitch fibers, enhanced endurance) but does not add muscle mass. MOTS-c improves muscle metabolic function and may help preserve muscle during aging. AOD 9604 has no muscle effects — it only affects adipose tissue. For muscle growth, GH secretagogues like CJC-1295 + Ipamorelin or Tesamorelin stimulate the full GH axis including anabolic signaling.
References
- Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PMID: 25738459
- Heffernan M, et al. Effects of AOD9604 on lipid metabolism in obese mice and beta(3)-AR knockout mice. Endocrinology. 2001;142(12):5182-5189. PMID: 11713213
- Kim SH, et al. ERR? agonist SLU-PP-332 enhances endurance exercise capacity. Nat Med. 2023.
About Proxiva Labs: We supply all three metabolic research peptides: MOTS-c, SLU-PP-332, and AOD 9604. Also available: Semaglutide, Tirzepatide, Retatrutide. Browse the complete research peptide catalog.
All products are sold strictly for research purposes only. Not for human consumption.
